Investor Alert

New York Markets Close in:

Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

Market open

/zigman2/quotes/201531540/composite

$

364.56

Change

-9.84 -2.63%

Volume

Volume 691,172

Jun 23, 2021, 11:48 a.m.

Real time quotes

/zigman2/quotes/201531540/composite

Previous close

$ 374.40

$ 364.56

Change

-9.84 -2.63%

Day low

Day high

$364.52

$376.01

Open
Open: 376.01

52 week low

52 week high

$223.25

$468.55

Open

Market cap

$56.37B

Average volume

1.98M

P/E ratio

19.28

Rev. per Employee

$1.36M

EPS

19.06

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. Pfizer argues its case in federal court for helping seniors meet drug copays

    32 min ago

    - Eleanor Laise

  2. Dow Sees Worst Week In 8 Months. Inflation Trade Sputters.

    4:45 p.m. June 18, 2021

    - Ben Levisohn

  3. Athira Pharma Falls 40% Amid Questions About CEO's PhD Research

    9:42 a.m. June 18, 2021

    - Josh Nathan-Kazis

  4. Biogen Stock Can Go 'Decisively Higher' on Sales of Alzheimer's Drug

    8:30 a.m. June 18, 2021

    - Josh Nathan-Kazis

  5. Biogen's FDA Win Marks a Mini-Rally in Biotech Stocks

    10:20 a.m. June 16, 2021

    - Josh Nathan-Kazis

  6. Alzheimer's Stock Alzamend Neuro Soars 170% in Week's First IPO

    4:40 p.m. June 15, 2021

    - Luisa Beltran

  7. Sage's Depression Drug Worked. Here's Why the Stock Is Falling.

    9:56 a.m. June 15, 2021

    - Josh Nathan-Kazis

  8. Sage, Biogen MDD treatment meets primary endpoint

    6:46 a.m. June 15, 2021

    - Tomi Kilgore

  9. Sage Therapeutics, Biogen depressive disorder treatment meets primary endpoint in Phase 3 study

    6:34 a.m. June 15, 2021

    - Tomi Kilgore

  10. Biogen price target raised to $647 from $458 at Truist Securities, stock rated buy

    7:56 a.m. June 14, 2021

    - Tonya Garcia

  11. Only ‘greedy’ drug companies will cure Alzheimer’s

    1:12 p.m. June 12, 2021

    - Brett Arends

  12. S&P 500 Ends the Week at New Record

    4:32 p.m. June 11, 2021

    - Barbara Kollmeyer

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. Biogen, Eisai respond to questions surrounding approval of Alzheimer's drug Aduhelm

    8:57 a.m. Today

    - Seeking Alpha

  2. FDA Approved Alzheimer’s Drug Despite Concerns

    6:21 p.m. June 22, 2021

    - Joseph Walker

  3. Cassava (SAVA) Stock Up on Alzheimer's Candidate Update

    10:22 a.m. June 22, 2021

    - Zacks.com

  4. The Attack on an Alzheimer’s Drug

    6:33 p.m. June 21, 2021

    - The Editorial Board

  5. Here's Why Prothena (PRTA) Stock Is Up So Far This Month

    3:17 p.m. June 21, 2021

    - Zacks.com

  6. What Happened to Sage Therapeutics Stock?

    6:21 a.m. June 21, 2021

    - Motley Fool

  7. Why Biogen Isn't a Buy After Its Alzheimer's Drug Approval

    2:02 p.m. June 20, 2021

    - Motley Fool

  8. The Post-Biogen, Post-Amyloid World For Alzheimer's Disease

    11:34 a.m. June 20, 2021

    - Seeking Alpha

  9. Alzheimer's Approval Validates Biopharmaceutical Innovation

    6:49 a.m. June 20, 2021

    - Seeking Alpha

  10. Did This Company Just Win Big Because of Biogen?

    5:33 a.m. June 20, 2021

    - Motley Fool

  11. Here's Why Sage Therapeutics Tanked This Week

    7:00 a.m. June 19, 2021

    - Motley Fool

  12. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.